视神经脊髓炎谱系疾病的研究进展(7)
[35] Pittock SJ，Lennon VA，McKeon A，et al. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders：an open-label pilot study [J]. Lancet Neurol，2013，12(6)：554-562.
[36] Kieseier BC，Stuve O，Dehmel T，et al. Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica：implication for cellular immune responses [J]. JAMA Neurol，2013，70(3)：390-393.
[37] Krampla W，Aboul-Enein F，Jecel J，et al. Spinal cord lesions in patients with neuromyelitis optica：a retrospective long-term MRI follow-up study [J]. Eur Radiol，2009，19(10)：2535-2543.
[38] Ringelstein M，Ayzenberg I，Harmel J，et al. Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder [J]. JAMA Neurol，2015，72(7)：756-763.
[39] Tradtrantip L，Zhang H，Saadoun S，et al. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica [J]. Ann Neurol，2012，71(3)：314-322.
[40] Kleiter I，Gahlen A，Borisow N，et al. Neuromyelitis optica：Evaluation of 871 attacks and 1，153 treatment courses [J]. Ann Neurol，2016，79(2)：206-216.
[41] Wingerchuk DM，Weinshenker BG. Neuromyelitis optica： clinical predictors of a relapsing course and survival [J]. Neurology，2003，60(5)：848-853.
(收稿日期：2018-05-11 本文編辑：张瑜杰), 百拇医药(王春琛 陈志刚 王洪 李彬 邢怡 王桂玲 刘春红)
[36] Kieseier BC，Stuve O，Dehmel T，et al. Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica：implication for cellular immune responses [J]. JAMA Neurol，2013，70(3)：390-393.
[37] Krampla W，Aboul-Enein F，Jecel J，et al. Spinal cord lesions in patients with neuromyelitis optica：a retrospective long-term MRI follow-up study [J]. Eur Radiol，2009，19(10)：2535-2543.
[38] Ringelstein M，Ayzenberg I，Harmel J，et al. Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder [J]. JAMA Neurol，2015，72(7)：756-763.
[39] Tradtrantip L，Zhang H，Saadoun S，et al. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica [J]. Ann Neurol，2012，71(3)：314-322.
[40] Kleiter I，Gahlen A，Borisow N，et al. Neuromyelitis optica：Evaluation of 871 attacks and 1，153 treatment courses [J]. Ann Neurol，2016，79(2)：206-216.
[41] Wingerchuk DM，Weinshenker BG. Neuromyelitis optica： clinical predictors of a relapsing course and survival [J]. Neurology，2003，60(5)：848-853.
(收稿日期：2018-05-11 本文編辑：张瑜杰), 百拇医药(王春琛 陈志刚 王洪 李彬 邢怡 王桂玲 刘春红)